SE422204B - Forfarande for framstellning av 5-((1-hydroxi-1-metyl)-etyl)-1-metyl-2-nitroimidazol - Google Patents

Forfarande for framstellning av 5-((1-hydroxi-1-metyl)-etyl)-1-metyl-2-nitroimidazol

Info

Publication number
SE422204B
SE422204B SE7600341A SE7600341A SE422204B SE 422204 B SE422204 B SE 422204B SE 7600341 A SE7600341 A SE 7600341A SE 7600341 A SE7600341 A SE 7600341A SE 422204 B SE422204 B SE 422204B
Authority
SE
Sweden
Prior art keywords
methyl
hydroxi
nitroimidazole
ethyl
preparing
Prior art date
Application number
SE7600341A
Other languages
English (en)
Swedish (sv)
Other versions
SE7600341L (sv
Inventor
A Assandri
G Lancini
G Volpe
B Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE7600341L publication Critical patent/SE7600341L/xx
Publication of SE422204B publication Critical patent/SE422204B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7600341A 1975-01-15 1976-01-14 Forfarande for framstellning av 5-((1-hydroxi-1-metyl)-etyl)-1-metyl-2-nitroimidazol SE422204B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1684/75A GB1480192A (en) 1975-01-15 1975-01-15 1-methyl-2-nitro-imidazole-5-methanol derivatives

Publications (2)

Publication Number Publication Date
SE7600341L SE7600341L (sv) 1976-07-16
SE422204B true SE422204B (sv) 1982-02-22

Family

ID=9726232

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600341A SE422204B (sv) 1975-01-15 1976-01-14 Forfarande for framstellning av 5-((1-hydroxi-1-metyl)-etyl)-1-metyl-2-nitroimidazol

Country Status (29)

Country Link
US (1) US4041168A (no)
JP (1) JPS5195069A (no)
AR (1) AR207804A1 (no)
AT (1) ATA13576A (no)
AU (1) AU8787575A (no)
BE (1) BE837595A (no)
CA (1) CA1062716A (no)
CH (1) CH609050A5 (no)
DD (1) DD123744A5 (no)
DE (1) DE2600538C3 (no)
DK (1) DK153839C (no)
ES (1) ES444324A1 (no)
FI (1) FI753726A (no)
FR (1) FR2297623A1 (no)
GB (1) GB1480192A (no)
GR (1) GR59991B (no)
IE (1) IE42462B1 (no)
IL (1) IL48751A0 (no)
IN (1) IN141389B (no)
LU (1) LU74172A1 (no)
NL (1) NL175413C (no)
NO (1) NO760113L (no)
NZ (1) NZ179762A (no)
PL (1) PL98602B1 (no)
PT (1) PT64695B (no)
RO (1) RO69138A (no)
SE (1) SE422204B (no)
SU (1) SU576043A3 (no)
ZA (1) ZA758017B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395341A (en) * 1977-07-21 1983-07-26 G. D. Searle & Co. Use of metronidazole in oil recovery
EP0024023B2 (de) * 1979-08-11 1992-11-11 Bayer Ag Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe
US4957918A (en) * 1988-06-09 1990-09-18 Leonard Bloom Topical treatment of blepharitis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065133A (en) * 1956-09-28 1962-11-20 Rhone Poulenc Sa Imidazoles for the control of histomoniasis
DE1470102A1 (de) * 1963-11-27 1969-05-29 Merck & Co Inc 2-Hydroxymethyl-5-nitroimidazole und Verfahren zu deren Herstellung
US3472864A (en) * 1964-03-18 1969-10-14 Merck & Co Inc 2-carbonyl-5-nitroimidazoles
NL124627C (no) * 1964-08-12
GB1051388A (no) * 1964-11-17
US3584007A (en) * 1968-09-16 1971-06-08 Merck & Co Inc Preparation of 1-substituted-2-hydroxymethyl - 5-nitroimidazoles employing chilorinated benzenes as the reaction medium
NL143227B (nl) * 1968-11-15 1974-09-16 Lepetit Spa Werkwijze ter bereiding van imidazoolderivaten met bactericide werking.
US3652579A (en) * 1969-06-26 1972-03-28 Hoffmann La Roche 1-methyl-2-substituted 5-nitroimidazoles
US3634446A (en) * 1969-10-06 1972-01-11 Hoffmann La Roche 1-methyl-2-isopropyl-5-nitroimidazole and water soluble salts thereof
DE2229248C3 (de) * 1971-07-30 1980-03-27 Gruppo Lepetit S.P.A., Mailand (Italien) 5-Iminomethyl-2-nitroimidazoI-Derivate und Verfahren zu deren Herstellung
US3828064A (en) * 1972-10-25 1974-08-06 Dow Chemical Co Method of preparing 1,5-disubstituted-2-nitroimidazoles

Also Published As

Publication number Publication date
GB1480192A (en) 1977-07-20
AR207804A1 (es) 1976-10-29
FR2297623B1 (no) 1979-06-22
GR59991B (en) 1978-03-28
IN141389B (no) 1977-02-19
RO69138A (ro) 1982-03-24
DK153839C (da) 1989-04-10
JPS5195069A (en) 1976-08-20
AU8787575A (en) 1977-06-30
NZ179762A (en) 1978-06-02
DE2600538B2 (de) 1978-05-24
IL48751A0 (en) 1976-02-29
NO760113L (no) 1976-07-16
NL175413C (nl) 1984-11-01
DE2600538C3 (de) 1979-01-18
FR2297623A1 (fr) 1976-08-13
ATA13576A (de) 1978-07-15
PL98602B1 (pl) 1978-05-31
DE2600538A1 (de) 1976-07-22
IE42462B1 (en) 1980-08-13
IE42462L (en) 1976-07-15
NL175413B (nl) 1984-06-01
DK153839B (da) 1988-09-12
DD123744A5 (no) 1977-01-12
NL7600284A (nl) 1976-07-19
PT64695B (fr) 1977-08-10
SU576043A3 (ru) 1977-10-05
CA1062716A (en) 1979-09-18
JPS5729033B2 (no) 1982-06-19
CH609050A5 (no) 1979-02-15
ES444324A1 (es) 1977-05-01
ZA758017B (en) 1976-12-29
LU74172A1 (no) 1976-07-20
DK12976A (da) 1976-07-16
US4041168A (en) 1977-08-09
PT64695A (fr) 1976-02-01
FI753726A (no) 1976-07-16
SE7600341L (sv) 1976-07-16
BE837595A (fr) 1976-07-15

Similar Documents

Publication Publication Date Title
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE7613973L (sv) Forfarande for framstellning av pappersmassa
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE428686B (sv) Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
SE423902B (sv) Forfarande for framstellning av purinderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE422794B (sv) Forfarande for framstellning av basiskt substituerade naftalenderivat
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7600341-7

Effective date: 19920806

Format of ref document f/p: F